High-throughput screening platform to identify allosteric modulators of proteins
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
134
NCT07038369
A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 29, 2025
Completion: Jan 31, 2029
Loading map...